The Value of Tumor Markers in Evaluating Chemotherapy Response and Prognosis in Chinese Patients with Advanced Non-Small Cell Lung Cancer

Publisher： Karger

E-ISSN： 1421-9794|56|6|417-423

ISSN： 0009-3157

Source： Chemotherapy, Vol.56, Iss.6, 2010-11, pp. : 417-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gefitinib Plus Interleukin-2 in Advanced Non-Small Cell Lung Cancer Patients Previously Treated with Chemotherapy

By Bersanelli Melissa   Buti Sebastiano   Camisa Roberta   Brighenti Matteo   Lazzarelli Silvia   Mazza Giancarlo   Passalacqua Rodolfo  

Cancers, Vol. 6, Iss. 4, 2014-09 ,pp. : 2035-2048

MDPI

Access to resources Recommend Favorite

Reply to the Letter to the Editor by C. Nicolazzo et al.: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy”

By Alama Angela   Coco Simona   Vanni Irene   Grossi Francesco  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1309-1309

MDPI

Access to resources Recommend Favorite

Letter to the Editor: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy”

By Nicolazzo Chiara   Raimondi Cristina   Loreni Flavia   Gazzaniga Paola   Gradilone Angela  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1308-1308

MDPI

Access to resources Recommend Favorite

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy

By Coco Simona   Alama Angela   Vanni Irene   Fontana Vincenzo   Genova Carlo   Dal Bello Maria Giovanna   Truini Anna   Rijavec Erika   Biello Federica   Sini Claudio   Burrafato Giovanni   Maggioni Claudia   Barletta Giulia   Grossi Francesco  

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-05 ,pp. : 1035-1035

MDPI

Access to resources Recommend Favorite

A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 58, Iss. 1, 2012-02 ,pp. : 78-83

Karger

Access to resources Recommend Favorite